Assessment | Time/place | ||||||
---|---|---|---|---|---|---|---|
0 | 2-4 | 6 | 12 | 18 | 24 | 60 | |
w | m | m | m | m | m | ||
GP | P | GP | GP | GP | P | P | |
Prescreening | X | ||||||
Informed consent | X | ||||||
Inclusion/exclusion criteria | X | ||||||
MARKO questionnaire | X | X | X | X | |||
CAT | X | X | X | ||||
SGRQ | X | X | X | ||||
History | X | X | X | ||||
Physical | X | X | X | ||||
EBT before and after cigarette | X | ||||||
Lung function | |||||||
COPD-6™ | X | X | X | X | X | ||
Spirometry with bronchodilator test | X | X | X | ||||
Impulse oscilometrya | X | ||||||
Lung diffusion capacity | X | ||||||
Body plethysmographya | X | ||||||
Blood sampling (hematology; highly sensitive C-reactive protein; blood | |||||||
stored for DNA, RNA, plasma and serum)b | X | ||||||
Functional exercise capacity (6-minute walk test) | X | ||||||
COPD diagnosis | X | X | X |